Opportunity Information: Apply for PAR 23 030
The Leading Equity and Diversity in the Medical Scientist Training Program (LEAD MSTP) (T32) is a National Institutes of Health training grant opportunity (PAR-23-030, CFDA 93.859) aimed at expanding and strengthening the clinician-scientist pipeline in the United States. Its central purpose is to develop a more diverse group of highly trained dual-degree clinician-scientist leaders who can meet the nations biomedical research needs. The program is designed for institutions that have historically been underrepresented among NIGMS-funded Medical Scientist Training Programs (MSTPs), with a clear emphasis on building equitable training environments and improving outcomes for trainees pursuing both a clinical professional degree and a Ph.D.
This opportunity supports institutions in creating and running dual-degree training programs that better integrate the major transition points that often make MD-PhD and similar pathways difficult to navigate. In practical terms, the FOA calls for evidence-informed approaches to training design and mentoring that help trainees move efficiently and successfully between medical (or other clinical) training phases and the research-intensive Ph.D. portion. Eligible clinical degrees are broad and can include M.D., D.O., D.V.M., D.D.S., Pharm.D., and related professional doctorates, paired with a research doctorate (Ph.D.). The intent is that graduates leave with deep scientific rigor and clinical insight so they can drive translational research that improves how diseases are understood, detected, treated, and prevented, while also being prepared to lead in the biomedical research enterprise as it continues to evolve.
NIGMS highlights several priorities that applicants are expected to address in their training plans. One is optimizing training efficiency, meaning programs should think carefully about curriculum structure, timing, milestones, and supports that reduce unnecessary delays and help trainees complete both degrees without sacrificing quality. Another is fostering long-term persistence in research careers, which points to building strong mentoring systems, research experiences, professional development, and career guidance that keep alumni engaged in biomedical research after graduation. A third priority is enhancing diversity in the clinician-scientist workforce, not only by recruiting diverse trainees but also by creating inclusive mentoring, community support, and career development structures that improve retention and success. Overall, NIGMS expects training programs to combine didactic instruction, meaningful research training, intentional mentoring, and career development activities so that trainees are well prepared for research careers with significant impact on national health-related research needs.
Eligibility is intentionally focused to expand capacity in specific institution types and regions. Applications are limited to domestic dual-degree training programs located at (1) Historically Black Colleges and Universities (HBCUs), (2) Tribal Colleges and Universities (TCUs), and (3) institutions in states and territories participating in the Institutional Development Award (IDeA) program, which is a congressionally mandated effort to build research capacity in historically underfunded states. The eligible applicant categories include public and state-controlled institutions of higher education and private institutions of higher education, as long as they meet the program limitations described above. Foreign institutions are not eligible to apply, and non-U.S. components of U.S. organizations are also not eligible.
Administratively, this is a discretionary grant using the NIH T32 institutional training mechanism, with the opportunity originally created on November 22, 2022, and an original application closing date of January 27, 2025. The source information provided does not specify an award ceiling or the expected number of awards, so applicants would need to consult the full FOA and NIH guidance for budget structure, allowable costs, trainee support levels, and any cohort expectations. In summary, LEAD MSTP is meant to broaden where MSTP-like training thrives, improve how dual-degree programs handle critical transitions, and produce clinician-scientists who are both scientifically excellent and more representative of the nations diversity, strengthening the future biomedical research workforce.Apply for PAR 23 030
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Leading Equity and Diversity in the Medical Scientist Training Program (LEAD MSTP)(T32)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.859.
- This funding opportunity was created on 2022-11-22.
- Applicants must submit their applications by 2025-01-27. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Public and State controlled institutions of higher education, Private institutions of higher education.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
LEAD MSTP (T32) Grant Opportunity FAQs
What is the LEAD MSTP (T32) grant opportunity?
The Leading Equity and Diversity in the Medical Scientist Training Program (LEAD MSTP) (T32) is a National Institutes of Health (NIH) institutional training grant opportunity intended to expand and strengthen the clinician-scientist pipeline in the United States by supporting dual-degree clinician-scientist training programs.
What is the central purpose of LEAD MSTP?
The central purpose is to develop a more diverse group of highly trained dual-degree clinician-scientist leaders who can meet the nation's biomedical research needs, with an emphasis on equitable training environments and improved trainee outcomes.
Which NIH institute is associated with the priorities described for this program?
The opportunity highlights priorities from NIGMS (the National Institute of General Medical Sciences), including training efficiency, long-term persistence in research careers, and enhancing diversity in the clinician-scientist workforce.
What kind of grant mechanism is used for LEAD MSTP?
LEAD MSTP uses the NIH T32 institutional training mechanism.
Is this a discretionary grant?
Yes. The opportunity is described as a discretionary grant.
What is the funding opportunity announcement (FOA) number and CFDA number?
The FOA is PAR-23-030 and the CFDA number listed is 93.859.
Who is this opportunity designed for?
It is designed for institutions that have historically been underrepresented among NIGMS-funded Medical Scientist Training Programs (MSTPs), with a clear emphasis on building equitable training environments and improving outcomes for dual-degree trainees.
What types of programs does LEAD MSTP support?
The opportunity supports institutions in creating and running dual-degree training programs that pair a clinical professional doctorate with a research doctorate (Ph.D.), and that better integrate major transition points that can be challenging in MD-PhD and similar pathways.
Which clinical degrees are considered eligible under this opportunity?
The eligible clinical degrees are described as broad and can include M.D., D.O., D.V.M., D.D.S., Pharm.D., and related professional doctorates, paired with a Ph.D.
What is meant by "dual-degree clinician-scientist" in this context?
In this context, it refers to trainees pursuing both a clinical professional degree (such as an M.D. or other eligible clinical doctorate) and a Ph.D., with the goal of graduating with both clinical insight and deep scientific training.
What are the major training challenges this program is trying to address?
The program specifically calls for approaches that improve how trainees navigate major transition points between clinical training phases and the research-intensive Ph.D. portion, with the aim of helping trainees move efficiently and successfully through both degrees.
What does NIGMS mean by optimizing training efficiency?
Optimizing training efficiency refers to designing curriculum structure, timing, milestones, and supports that reduce unnecessary delays and help trainees complete both degrees without sacrificing training quality.
What does the program emphasize about mentoring and training design?
The FOA calls for evidence-informed approaches to training design and mentoring that support successful progression through both clinical and Ph.D. components, especially across transition points.
What does "long-term persistence in research careers" mean in the LEAD MSTP context?
It points to building mentoring systems, research experiences, professional development, and career guidance that help graduates remain engaged in biomedical research after they complete the program.
How does LEAD MSTP address diversity and equity?
The opportunity prioritizes enhancing diversity in the clinician-scientist workforce not only through recruitment of diverse trainees, but also by creating inclusive mentoring, community support, and career development structures that improve retention and success.
What types of training activities are expected to be included in a training plan?
NIGMS expects training programs to combine didactic instruction, meaningful research training, intentional mentoring, and career development activities to prepare trainees for impactful research careers aligned with national health-related research needs.
What outcomes is the program aiming for among graduates?
The intent is for graduates to leave with strong scientific rigor and clinical insight so they can drive translational research that improves how diseases are understood, detected, treated, and prevented, and be prepared to lead in the evolving biomedical research enterprise.
Which institutions are eligible to apply?
Applications are limited to domestic dual-degree training programs located at: (1) Historically Black Colleges and Universities (HBCUs), (2) Tribal Colleges and Universities (TCUs), and (3) institutions in states and territories participating in the Institutional Development Award (IDeA) program.
What is the IDeA program and why does it matter for eligibility?
The Institutional Development Award (IDeA) program is described as a congressionally mandated effort to build research capacity in historically underfunded states. Institutions in IDeA states and territories are included in the eligibility limitations for this opportunity.
Are both public and private institutions eligible?
Yes. Eligible applicant categories include public and state-controlled institutions of higher education and private institutions of higher education, as long as they meet the program limitations (HBCU, TCU, or IDeA-state/territory location).
Are foreign institutions eligible to apply?
No. Foreign institutions are not eligible to apply.
Are non-U.S. components of U.S. organizations eligible?
No. Non-U.S. components of U.S. organizations are also not eligible.
Is the program limited to MD-PhD programs only?
No. While MD-PhD pathways are referenced as an example, the opportunity describes eligible clinical degrees broadly (including M.D., D.O., D.V.M., D.D.S., Pharm.D., and related professional doctorates) when paired with a Ph.D.
When was this opportunity originally created?
The opportunity was originally created on November 22, 2022.
What is the original application closing date?
The original application closing date provided is January 27, 2025.
Does the provided information list an award ceiling or expected number of awards?
No. The source information provided does not specify an award ceiling or the expected number of awards.
Where should applicants look for budget structure, allowable costs, and trainee support details?
Based on the information provided, applicants would need to consult the full FOA and NIH guidance for budget structure, allowable costs, trainee support levels, and any cohort expectations.
In one sentence, what is LEAD MSTP trying to accomplish?
LEAD MSTP is meant to broaden where MSTP-like training thrives, improve how dual-degree programs handle critical transitions, and produce clinician-scientists who are scientifically excellent and more representative of the nation's diversity.
Browse more opportunities from the same category: Health
Next opportunity: NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)
Previous opportunity: HEAL Initiative: HEAL Data2Action Acceleration Projects (R33 Clinical Trial Not Allowed)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 23 030
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 23 030) also looked into and applied for these:
| Funding Opportunity |
|---|
| International Centers of Excellence for Malaria Research (U19 Clinical Trial Not Allowed) Apply for RFA AI 22 067 Funding Number: RFA AI 22 067 Agency: National Institutes of Health Category: Health Funding Amount: $800,000 |
| Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional) Apply for PAR 23 054 Funding Number: PAR 23 054 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional) Apply for PAR 23 053 Funding Number: PAR 23 053 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Mozambique Local Tuberculosis Response II Apply for 72065623 RFI TBCONTROL Funding Number: 72065623 RFI TBCONTROL Agency: Mozambique USAID-Maputo Category: Health Funding Amount: Case Dependent |
| Social Drivers of Mental Illnesses in Low- and Middle-Income Countries: Mechanisms and Pathways of Interventions for Youth (R01 Clinical Trial Optional) Apply for RFA MH 23 310 Funding Number: RFA MH 23 310 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Mozambique Local Tuberculosis Response II Apply for 720656 RFI TBCONTROL Funding Number: 720656 RFI TBCONTROL Agency: Mozambique USAID-Maputo Category: Health Funding Amount: Case Dependent |
| Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required) Apply for PAR 22 256 Funding Number: PAR 22 256 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed) Apply for PAR 23 065 Funding Number: PAR 23 065 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed) Apply for RFA RM 23 003 Funding Number: RFA RM 23 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIH Research Evaluation and Commercialization Hubs (REACH) Awards (U01 Clinical Trial Optional) Apply for RFA OD 23 002 Funding Number: RFA OD 23 002 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed) Apply for PAR 23 036 Funding Number: PAR 23 036 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required) Apply for PAR 23 057 Funding Number: PAR 23 057 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIH Research Evaluation and Commercialization Hubs (REACH) Awards (U01 Clinical Trial Optional) Apply for RFA OD 23 005 Funding Number: RFA OD 23 005 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| Implementation Research on Noncommunicable Disease Risk Factors among Low- and Middle-Income Country and Tribal Populations Living in City Environments (R61/R33 Clinical Trial Required) Apply for PAR 23 043 Funding Number: PAR 23 043 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Research Networks to Promote Multidisciplinary Mechanistic Studies on Music-Based Interventions for Pain or Alzheimers Disease and Alzheimers Disease Related Dementias (AD/ADRD) (U24 Clinical Trial Optional) Apply for RFA AT 23 008 Funding Number: RFA AT 23 008 Agency: National Institutes of Health Category: Health Funding Amount: $300,000 |
| Interorgan Communication in Aging (U01 Clinical Trial Not Allowed) Apply for RFA AG 24 005 Funding Number: RFA AG 24 005 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Clinical Studies of Mental Illness (Collaborative R01) (Clinical Trial Optional) Apply for PAR 23 050 Funding Number: PAR 23 050 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition: Resources and Workforce Development for the Regional Biocontainment Laboratories (UC7 Clinical Trial Not Allowed) Apply for RFA AI 22 075 Funding Number: RFA AI 22 075 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| NIH StrokeNet- Regional Coordinating Stroke Centers for year 2023 (U24 - Clinical Trials Not Allowed) Apply for RFA NS 23 010 Funding Number: RFA NS 23 010 Agency: National Institutes of Health Category: Health Funding Amount: $1,750,000 |
| NIH StrokeNet National Coordinating Center for year 2023 (U01 Clinical Trials Not Allowed) Apply for RFA NS 23 009 Funding Number: RFA NS 23 009 Agency: National Institutes of Health Category: Health Funding Amount: $1,750,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 23 030", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.